Fig. 2

T817MA attenuates neuroinflammation after brain ischemia. (A and B) Immunostaining (A) and quantitative analysis (B) show that T817MA decreases the number of Iba-1 positive cells after brain ischemia. (C,D) Immunostaining (C) and quantitative analysis (D) show that T817MA decreases the number of GFAP positive cells after brain ischemia. Scale bar = 50 μm. n = 3 in each group. Data are shown as mean ± SD. #p < 0.05 vs. Sham group. *p < 0.05 vs. MCAO group.